MinervaX
General Information
Identification Code: 368349831585-45
Website: http://www.minervax.com
Entity Form: ApS (Company)
Registration Category: Companies & groups
Registration Date: 5/21/2018
Last Update: 7/28/2023
Mission & Interests
Goals: MinervaX has advanced its GBS vaccine through clinical trials in 300 healthy adult women with very encouraging results and is the leading vaccine candidate currently in development.
MinervaX is currently engaged in Phase 2 clinical studies, of which one is supported by an EDCTP grant.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Public health
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: Mr Per Fischer, representative of MinervaX, would like to introduce the company to EC members and explore how our capabilities within our industry could be leveraged to achieve the goals within the European Commission.
MinervaX will be visiting Brussels to attend meetings with various EU Institutions and agencies to discuss feasibility of gaining support relating to the vaccine against Group B Streptococcus (GBS) that is currently undergoing clinical trials.
However, our offerings are broad and deep, and we are also keen to gain insight from the EC members as to their perspectives on how MinervaX could bring value to ongoing and future EC needs in the Health Industry across a more comprehensive landscape.
MinervaX intends to apply under Horizon 2020 or other appropriate funding.
Inter-institutional or Unofficial Groupings: SME
Head Office
Address: Ole Maaloes Vej 3
Post Code: 2200
City: Copenhagen
Country: DENMARK
Phone:
Indic Phone: 45
Phone Number: 53 88 30 02
EU Office
Address: Ole Maaloes Vej 3
Post Code: 2200
City: Copenhagen
Country: DENMARK
Phone:
Indic Phone: 45
Phone Number: 53 88 30 02
Financial Data
Closed Year:
Start Date:
End Date:
Funding Sources:
Contributions:
Total Budget: 0
Grants:
- Source: EDTCPAmount: 0Currency: €_id:Buffer:0: 1041: 642: 613: 1504: 1585: 2126: 1827: 328: 869: 9010: 8111: 17
Current Year:
Grants:
Membership Information
Members10 Percent: 1
Members: 1
Members F T E: 0.10000000149011612
Structure
Structure Type: Structure
Is Member Of: Dansk Biotek (www.danskbiotek.dk)
Current Job Opportunities
mid-levelBrussels, Francefull-time
Posted: 8/21/2025